fda glp-1 warning letters october 2025 New Study Finds Compounded GLP-1s Remain Robust Despite End of Shortages FDA Warns Novo Nordisk on

doi: 10.1097/PRA.0000000000000578

Sodium tanshinone IIA sulfonate injection as adjunctive therapy for the treatment of heart failure: a systematic review and meta-analysis

Dose equivalency between semaglutide and tirzepatide is not straightforward because the compounds differ in receptor selectivity, with tirzepatide acting on both GIP and GLP-1 receptors while semaglutide targets GLP-1 exclusively

Activation of mTOR in Alzheimers disease Insulin resistance or impaired insulin sensitivity is typical in AD and can be developed by activation of the mTOR (mammalian target of rapamycin) (Arnold et al

at rest is very different from heart racing when standing up , as is found in POTS (postural tachycardia syndrome), a form of orthostatic intolerance